Gemfibrozzi API

Name	Gemfibrozzi
Chinese name	吉非罗齐
Cas Number	25812-30-0
Source	India
Qualifications	USDMF/CEP/-/-/-

Gemfibrozil is a non-halogenated clofibrate lipid-lowering drug, which can effectively reduce total cholesterol, total triglycerides, very low density lipoprotein cholesterol and triglycerides, low density lipoprotein cholesterol and The content of triglycerides increases the concentration of high-density lipoprotein cholesterol. Gemfibrozil overcomes the severe toxic and side effects of the previous hypolipidemic drug Antomin on the liver, retains its effective effect, helps reduce the incidence of myocardial infarction, and can be taken for a long time. Because of its safety and reliability, it has been included in the United States Pharmacopoeia. , Become a legal drug. Animal and clinical trials have shown that its blood lipid-lowering effect is better than its homologues. At present, there are not many drugs that can effectively reduce TC, TG, LDL-C and increase HDL-C in clinical practice, and some of them have certain side effects. Over the years, clinical evidence has shown that gemfibrozil has obvious therapeutic effects and low side effects, which provides a better medicine for patients with hyperlipidemia. In 2016, the total scale of blood lipid-lowering drugs nationwide reached 18.5 billion (hospitals and retail pharmacies), an 11.4% year-on-year increase from 16.4 billion in 2015, and the annual growth rate exceeded 8.0% for three consecutive years. As my country's aging progress accelerates and the proportion of elderly people increases, the market size of lipid-lowering drugs will maintain a relatively high growth trend in the next few years.

Hot Tags: gemfibrozzi api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Pleasant API, Brinzolamide API, Tetrabenazine API, Dimethyl Fumarate API, Tavaborol API, Clofarabine API

• Previous: Corticotropin API
• Next: Aclidinium Bromide API